Contribution of proteomics to the study of the role of cytokeratins in disease and physiopathology

被引:9
作者
Brouillard, Franck [1 ,2 ]
Fritsch, Janine [1 ,3 ]
Edelman, Aleksander [1 ,2 ,3 ]
Ollero, Mario [1 ,3 ]
机构
[1] INSERM, U845, Fac Med Necker, F-75015 Paris, France
[2] Univ Paris 05, Fac Med Rene Descartes, Paris, France
[3] Univ Paris 05, Fac Med Rene Descartes, Paris, France
关键词
biomarkers; interactomics; intermediate filaments; keratin; 2-DIMENSIONAL GEL-ELECTROPHORESIS; EPIDERMAL-GROWTH-FACTOR; SQUAMOUS-CELL CARCINOMA; TRANSMEMBRANE CONDUCTANCE REGULATOR; TANDEM MASS-SPECTROMETRY; BREAST-CANCER CELLS; HUMAN KERATIN 8; EPITHELIAL-CELLS; PROTEIN EXPRESSION; INTERMEDIATE-FILAMENTS;
D O I
10.1002/prca.200780018
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cytokeratins (CKs), the most abundant group of cytoskeletal intermediate filaments, and proteomics are strongly connected. On the one hand, proteomics has been extremely useful to uncover new features and functions of CKs, on the other, the highly abundant CKs serve as an exceptional tool to test new technological developments in proteomics. As a result, proteomics has contributed to finding valuable associations of CKs with diseases as diverse as cancer, cystic fibrosis, steatohepatitis, viral and bacterial infection, keratoconus, vitreoretinopathy, pre-eclampsia or the chronic fatigue syndrome, as well as to characterizing their participation in a number of physiopathological processes, including drug resistance, response to toxicants, inflammation, stem cell differentiation, embryo development, and tissue repair. In some cases, like in cystic fibrosis, CKs have been described as potential therapeutic targets. The development of a specific field of proteornics where CKs become the main subject of research aims and hypotheses is suggested.
引用
收藏
页码:264 / 285
页数:22
相关论文
共 185 条
[1]   HUMAN MONOCLONAL-ANTIBODIES AGAINST CYTOKERATIN-18 GENERATED FROM PATIENTS WITH GASTRIC-CANCER [J].
ABE, T ;
FUKUMOTO, M ;
TSUCHIYA, K ;
KURAMOCHI, K ;
FURUTA, T ;
TOGOH, S ;
NISHIYAMA, K ;
TSUCHIYA, S .
JAPANESE JOURNAL OF CANCER RESEARCH, 1989, 80 (03) :271-276
[2]   Glucose-induced changes of multiple mouse islet proteins analysed by two-dimensional gel electrophoresis and mass spectrometry [J].
Ahmed, M ;
Bergsten, P .
DIABETOLOGIA, 2005, 48 (03) :477-485
[3]   Polypeptide expression in prostate hyperplasia and prostate adenocarcinoma [J].
Alaiya, A ;
Roblick, U ;
Egevad, L ;
Carlsson, A ;
Franzén, B ;
Volz, D ;
Huwendiek, S ;
Linder, S ;
Auer, G .
ANALYTICAL CELLULAR PATHOLOGY, 2000, 21 (01) :1-9
[4]   Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry [J].
Alaiya, AA ;
Oppermann, M ;
Langridge, J ;
Roblick, U ;
Egevad, L ;
Brändstedt, S ;
Hellström, M ;
Linder, S ;
Bergman, T ;
Jörnvall, H ;
Auer, G .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2001, 58 (02) :307-311
[5]   Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis [J].
Alfonso, P ;
Núñez, A ;
Madoz-Gurpide, J ;
Lombardia, L ;
Sánchez, L ;
Casal, JI .
PROTEOMICS, 2005, 5 (10) :2602-2611
[6]   Comparative proteome analysis of native differentiated and cultured dedifferentiated human RPE cells [J].
Alge, CS ;
Suppmann, S ;
Priglinger, SG ;
Neubauer, AS ;
May, CA ;
Hauck, S ;
Welge-Lussen, U ;
Ueffing, M ;
Kampik, A .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (08) :3629-3641
[7]   Radioresistance-related proteins in rectal cancer [J].
Allal, AS ;
Kähne, T ;
Reverdin, AK ;
Lippert, H ;
Schlegel, W ;
Reymond, MA .
PROTEOMICS, 2004, 4 (08) :2261-2269
[8]  
Ameen NA, 2001, J CELL SCI, V114, P563
[9]   Identification of proteins in activated human neutrophils susceptible to tyrosyl radical attack. A proteomic study using a tyrosylating fluorophore [J].
Avram, D ;
Romijn, EP ;
Pap, EHW ;
Heck, AJR ;
Wirtz, KWA .
PROTEOMICS, 2004, 4 (08) :2397-2407
[10]   Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients [J].
Bae, SM ;
Lee, CH ;
Cho, YL ;
Nam, KH ;
Kim, YW ;
Kim, CK ;
Han, BD ;
Lee, YJ ;
Chun, HJ ;
Ahn, WS .
GYNECOLOGIC ONCOLOGY, 2005, 99 (01) :26-35